Related Experiment Video

Updated: Jul 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Human immunodeficiency virus-infected patients with community-acquired pneumonia: implication of respiratory

Rafael Perelló1, Asunción Moreno, Marta Camps

  • 1Servicio de Infecciones, Hospital Clínic-IDIBAPS, Barcelona, España. rperello@clinic.ub.es

Enfermedades Infecciosas Y Microbiologia Clinica
|March 18, 2008
PubMed

Insights

Respiratory viruses were found in community-acquired pneumonia (CAP) cases among human immunodeficiency virus (HIV)-infected patients. This viral infection did not lead to a worse prognosis in these patients.

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunology

Context:

  • Community-acquired pneumonia (CAP) is a significant concern in human immunodeficiency virus (HIV)-infected individuals.
  • The specific role of respiratory viruses in CAP within this population remains under-investigated.
  • This study addresses a gap in understanding viral etiologies of CAP in immunocompromised patients.

Purpose:

  • To investigate the implication and impact of respiratory viruses in cases of CAP among HIV-infected patients.
  • To determine if respiratory viral infections influence the disease course or prognosis in HIV-associated CAP.
  • To prospectively analyze viral pathogens contributing to pneumonia in a tertiary hospital setting.

Summary:

  • Respiratory viruses were identified in 14 out of 67 CAP cases in HIV patients.
  • In 8 cases, respiratory viruses were the sole identified pathogen.
  • The clinical evolution of CAP was comparable between patients with and without respiratory viral coinfection.

Impact:

  • Respiratory viral infections in HIV-infected patients with CAP are not associated with a poorer prognosis.
  • Findings suggest that viral CAP in HIV patients may be managed similarly to bacterial CAP.
  • This research contributes to evidence-based guidelines for managing pneumonia in immunocompromised populations.

More Related Videos

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: